Molecular Gene Signature and Prognosis of Non-Small Cell Lung Cancer

Oncotarget - United States
doi 10.18632/oncotarget.10622
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

A Chromosomal Passenger Complex Protein Signature Model Predicts Poor Prognosis For non-Small-Cell Lung Cancer

OncoTargets and Therapy
OncologyPharmacology
2015English

P1.03-32 Molecular Characteristics and Prognosis FBXW7 Mutations in Chinese Non-Small-Cell Lung Cancer Patients

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

SCUBE3 Overexpression Predicts Poor Prognosis in Non-Small Cell Lung Cancer

BioScience Trends
BiochemistryHealthMedicineGeneticsMolecular Biology
2013English

Correlation of Neuroendocrine Features With Prognosis of Non-Small Cell Lung Cancer

Oncotarget
Oncology
2016English

Prognostic Gene Signatures for Non-Small-Cell Lung Cancer

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2009English

Expression of THOP1 and Its Relationship to Prognosis in Non-Small Cell Lung Cancer

PLoS ONE
Multidisciplinary
2014English

Non-Small Cell Lung Cancer

English

Reduced Expression of FADS1 Predicts Worse Prognosis in Non-Small-Cell Lung Cancer

Journal of Cancer
Oncology
2016English

Prognosis of Non-Small-Cell Lung Cancer in Patients With Idiopathic Pulmonary Fibrosis

Scientific Reports
Multidisciplinary
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy